Innova Captab reports 31.1% revenue growth in FY26

2 min read     Updated on 08 Jun 2026, 05:51 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Innova Captab Limited reported a 31.1% increase in consolidated revenue to ₹1,630.02 crore for FY26, with PAT rising 9.9% to ₹140.92 crore. The CDMO segment grew 23.8%, while Branded Generics surged 51.4%. The company announced its 22nd AGM on June 29, 2026, via video conferencing, with remote e-voting open from June 26 to June 28.

powered bylight_fuzz_icon
42034476

*this image is generated using AI for illustrative purposes only.

Innova Captab Limited reported a 31.1% increase in consolidated revenue from operations to ₹1,630.02 crore for the financial year ended March 31, 2026, compared to ₹1,243.68 crore in the previous year. Profit After Tax (PAT) rose 9.9% to ₹140.92 crore. The company has convened its 22nd Annual General Meeting on June 29, 2026, via video conferencing to adopt the audited financial statements and consider director re-appointments. Additionally, the company communicated the specific web link for accessing the Annual Report 2025-26 to shareholders in compliance with SEBI LODR amendments.

Key AGM Details

The 22nd AGM will be held on Monday, June 29, 2026, at 11:30 AM IST. The record date for determining shareholder eligibility is June 22, 2026. Remote e-voting is available from June 26, 2026, at 09:00 AM IST until June 28, 2026, at 05:00 PM IST. The agenda includes the re-appointment of M/s. B S R & Co. LLP as Statutory Auditors for a five-year term and the ratification of Cost Auditor remuneration. Ms. Sandhya R Malhotra, Partner of M/s. Manish Ghia & Associates, has been appointed as the Scrutinizer for the e-voting process.

Event Date Time
AGM Date June 29, 2026 11:30 AM IST
Record Date June 22, 2026
E-Voting Start June 26, 2026 09:00 AM IST
E-Voting End June 28, 2026 05:00 PM IST

FY2025-26 Financial Performance

The company delivered strong consolidated results, with EBITDA growing 26.3% to ₹250.34 crore. On a standalone basis, revenue increased 35.6% to ₹12,988.14 million, while standalone profit declined 6.46% to ₹836.92 million due to fixed costs at the Kathua facility. The board declared an interim dividend of ₹2 per share during the year.

Metric FY2025-26 FY2024-25 Change (%)
Revenue from Operations ₹1,630.02 crore ₹1,243.68 crore +31.1%
EBITDA ₹250.34 crore ₹198.20 crore +26.3%
EBITDA Margin ~15.4% ~15.9%
Profit After Tax (PAT) ₹140.92 crore ₹128.26 crore +9.9%

Business Segment Performance

Innova Captab restructured operations into CDMO Services & Products and Branded Generics. The CDMO segment contributed 70% of total revenue, growing 23.8% to ₹1,133.35 crore. The Branded Generics segment surged 51.4% to ₹496.67 crore. Exports accounted for 31.3% of total revenue, with the company serving over 350 clients across 60+ countries.

Segment FY2025-26 FY2024-25 YoY Growth
CDMO Revenue ₹1,133.35 crore ₹915.62 crore +23.8%
Branded Generics Revenue ₹496.67 crore ₹328.06 crore +51.4%

Operational Highlights

The greenfield facility at Kathua, Jammu commenced operations in January 2025 and achieved full-year operations in FY2026, receiving WHO-GMP and PIC/S certifications. The Baddi facility secured UK-MHRA GMP compliance certification. R&D investment increased to ₹7.00 crore from ₹6.55 crore in the previous year. The company's market capitalisation stood at ₹3,948 crore as on March 31, 2026.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
+5.61%+6.57%+16.27%+39.06%+14.74%+83.64%

How will the recent WHO-GMP and PIC/S certifications at the Kathua facility impact the company's ability to secure new international CDMO contracts?

What strategies will management employ to bridge the margin gap, given that EBITDA growth lagged behind revenue expansion?

With Branded Generics growing over 50%, will the company look to rebalance its revenue mix away from the current 70% reliance on CDMO services?

Innova Captab files BRSR for FY26, exports rise to 23%

1 min read     Updated on 04 Jun 2026, 06:56 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Innova Captab Limited filed its BRSR for FY26, reporting exports of ₹2,976.77 million (23% of turnover) and a CSR spend of ₹20.83 million. The company, which achieved full-year operations at its Kathua facility, set targets for net zero by 2040 and confirmed compliance with environmental regulations.

powered bylight_fuzz_icon
42125171

*this image is generated using AI for illustrative purposes only.

Innova Captab Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, detailing its environmental, social, and governance (ESG) performance. The filing, made to BSE Limited and National Stock Exchange of India Limited, highlights a significant increase in export contribution, which rose to 23% of total turnover, amounting to ₹2,976.77 million, compared to ₹1,481.98 million (16%) in the previous year.

The company reported a total turnover of ₹12,988.14 million and a net worth of ₹8,866.54 million for the reporting period. Its Corporate Social Responsibility (CSR) expenditure for the year stood at ₹20.83 million. The report notes that the Kathua, Jammu facility became operational on 14 January 2025 and operated for the full year in FY 2026, resulting in higher figures across relevant operational parameters compared to the previous year.

Operational and Financial Metrics

Innova Captab's operations are primarily focused on the manufacturing of pharmaceuticals, which accounted for 100% of its turnover. The company serves a global market, exporting to 29 countries, while its domestic reach spans PAN India. As of the end of the financial year, the company employed 1,105 permanent employees and 1,193 permanent workers across three national plants and two offices.

Metric FY 2026 FY 2025
Exports (₹ million) 2,976.77 1,481.98
Export Contribution 23% 16%
CSR Spend (₹ million) 20.83 -
Turnover (₹ million) 12,988.14 -

Sustainability and Governance Commitments

The company has established specific environmental targets, including achieving net zero by 2040, water neutrality by 2030, and reducing Scope 1 and Scope 2 GHG emissions by 40% and 25% respectively by 2035. Governance oversight is led by Jayant Vasudeo Rao, Whole-Time Director, who is responsible for sustainability-related decisions. The Board has approved comprehensive policies covering all nine principles of the National Guidelines on Responsible Business Conduct (NGRBC).

Environmental Performance

The report details the company's energy and water consumption, as well as waste management metrics. Total energy consumed increased to 207,825,995 Mega Joules in FY 2026 from 115,250,856 Mega Joules in FY 2025, driven by the expanded operations. Water withdrawal totaled 208,771 kiloliters, and the company generated 52.90 metric tonnes of waste. Innova Captab confirmed compliance with all applicable environmental laws and regulations, reporting no major non-compliances for FY 2026.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
+5.61%+6.57%+16.27%+39.06%+14.74%+83.64%

How will the operationalization of the Kathua facility influence the company's profit margins given the simultaneous rise in energy consumption?

What specific strategies will Innova Captab employ to meet its aggressive 2030 water neutrality target as production scales up?

Are there plans to further diversify the export portfolio beyond the current 29 countries to sustain the 23% export growth rate?

More News on Innova Captab

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+14.74%